Jason P. Rhodes - Jun 9, 2022 Form 4 Insider Report for Generation Bio Co. (GBIO)

Role
Director
Signature
/s/ Jennifer Elliott, Attorney-in-Fact
Stock symbol
GBIO
Transactions as of
Jun 9, 2022
Transactions value $
$0
Form type
4
Date filed
6/13/2022, 04:05 PM
Previous filing
Jun 6, 2022
Next filing
Dec 14, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GBIO Stock Option (right to buy) Award $0 +19.2K $0.00 19.2K Jun 9, 2022 Common Stock 19.2K $6.19 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on June 9, 2022. The shares underlying the option will fully vest on the earlier of: June 9, 2023 and the date of Generation Bio's 2023 annual meeting of stockholders.
F2 The Reporting Person is a member of Atlas Venture Associates X, LLC and is obligated to transfer the economic benefit, if any, received upon the sale of the shares issuable upon exercise of the option to Atlas Venture Life Science Advisors, LLC. As such, the Reporting Person disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of his pecuniary interest therein, if any.